Prognostic factors for the efficacy of catumaxomab in patients (pts) with malignant ascites (MA): Meta-analysis from two phase III studies.

被引：0
|
作者：
Friccius-Quecke, Hilke
Heiss, Markus M.
Lordick, Florian
Parsons, Simon L.
Wimberger, Pauline
Bokemeyer, Carsten
机构：
[1] Fresenius Biotech GmbH, Munich, Germany
[2] Univ Witten Herdecke, Cologne Merheim Med Ctr, Cologne, Germany
[3] Univ Canc Ctr Leipzig, Leipzig, Germany
[4] Nottingham Univ NHS Trust, Nottingham, England
[5] Tech Univ Dresden, Dept Gynecol & Obstet, D-01062 Dresden, Germany
[6] Univ Med Ctr Hamburg Eppendorf, Dept Oncol Hematol & BMT, Sect Pneumol, Hamburg, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3078
引用
收藏
页数：1
相关论文
共 50 条
  • [1] PROGNOSTIC FACTORS FOR THE EFFICACY OF CATUMAXOMAB IN PATIENTS WITH MALIGNANT ASCITES (MA) DUE TO OVARIAN CANCER (OC): META-ANALYSIS FROM TWO PHASE III STUDIES
    Sehouli, J.
    Heiss, M.
    Lordick, F.
    Parsons, S. L.
    Wimberger, P.
    Marschner, A.
    Wagner, U.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [2] Pooled analysis of two phase III studies provides prognostic indicators for clinical outcome after catumaxomab treatment for malignant ascites
    Bokemeyer, C.
    Heiss, M. M.
    Lordick, F.
    Parsons, S. L.
    Wimberger, P.
    Friccius-Quecke, H.
    ONKOLOGIE, 2013, 36 : 273 - 274
  • [3] Pooled analysis of two phase III studies provides prognostic indicators for clinical out-come after catumaxomab treatment for malignant ascites
    Bokemeyer, C.
    Heiss, M. M.
    Lordick, F.
    Parsons, S. L.
    Wimberger, P.
    Friccius-Quecke, H.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S212 - S213
  • [4] Quality of Life in Patients With Malignant Ascites and Ascites Symptoms After Treatment With Catumaxomab: Results From a Multicenter Phase II/III Study Comparing Paracentesis Plus Catumaxomab With Paracentesis Alone
    Gonschior, A.
    Gilet, H.
    Heisss, M. M.
    Hennig, M.
    Moehler, M.
    Schmalfeldt, B.
    Schulze, E.
    Wimberger, P.
    Parsons, S. L.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S223 - S223
  • [5] Quality of life in patients with malignant ascites and after treatment with catumaxomab: results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone
    Schmalfeldt, B.
    Seck, K.
    Gonschior, A. K.
    Gilet, H.
    Heiss, M.
    Hennig, M.
    Moehler, M.
    Schulze, E.
    Wimberger, P.
    Parsons, S. L.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2012, 72 (04)
  • [6] The Role of Relative Lymphocyte Count as a Biomarker for the Effect of Catumaxomab on Survival in Malignant Ascites Patients: Results from a Phase II/III Study
    Heiss, Markus M.
    Stroehlein, Michael A.
    Bokemeyer, Carsten
    Arnold, Dirk
    Parsons, Simon L.
    Seimetz, Diane
    Lindhofer, Horst
    Schulze, Elisabeth
    Hennig, Michael
    CLINICAL CANCER RESEARCH, 2014, 20 (12) : 3348 - 3357
  • [7] Treatment with the trifunctional antibody catumaxomab followed by systemic chemotherapy: Results of a subgroup analysis from a phase III study in patients with relapsed ovarian cancer and malignant ascites
    Chekerov, R.
    Wimberger, P.
    Vergote, I.
    Schneeweiss, A.
    Scambia, G.
    Colombo, N.
    Guastalla, J. P.
    Lordick, F.
    Schulze, E.
    Sehouli, J.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S742 - S742
  • [8] Prognostic significance of malignant ascites in gastric cancer patients with peritoneal metastasis: A systemic review and meta-analysis
    Ling-Nan Zheng
    Feng Wen
    Ping Xu
    Shuang Zhang
    World Journal of Clinical Cases, 2019, 7 (20) : 3247 - 3258
  • [9] Prognostic significance of malignant ascites in gastric cancer patients with peritoneal metastasis: A systemic review and meta-analysis
    Zheng, Ling-Nan
    Wen, Feng
    Xu, Ping
    Zhang, Shuang
    WORLD JOURNAL OF CLINICAL CASES, 2019, 7 (20) : 3247 - 3258
  • [10] Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies
    Bruix, Jordi
    Cheng, Ann-Lii
    Meinhardt, Gerold
    Nakajima, Keiko
    De Sanctis, Yoriko
    Llovet, Josep
    JOURNAL OF HEPATOLOGY, 2017, 67 (05) : 999 - 1008
12345